<?xml version="1.0" encoding="utf-8"?>
<TEI xmlns="http://www.tei-c.org/ns/1.0" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:hal="http://hal.archives-ouvertes.fr/" xmlns:gml="http://www.opengis.net/gml/3.3/" xmlns:gmlce="http://www.opengis.net/gml/3.3/ce" version="1.1" xsi:schemaLocation="http://www.tei-c.org/ns/1.0 http://api.archives-ouvertes.fr/documents/aofr-sword.xsd">
  <teiHeader>
    <fileDesc>
      <titleStmt>
        <title>HAL TEI export of hal-03665871</title>
      </titleStmt>
      <publicationStmt>
        <distributor>CCSD</distributor>
        <availability status="restricted">
          <licence target="https://creativecommons.org/publicdomain/zero/1.0/">CC0 1.0 - Universal</licence>
        </availability>
        <date when="2026-05-02T13:51:24+02:00"/>
      </publicationStmt>
      <sourceDesc>
        <p part="N">HAL API Platform</p>
      </sourceDesc>
    </fileDesc>
  </teiHeader>
  <text>
    <body>
      <listBibl>
        <biblFull>
          <titleStmt>
            <title xml:lang="en">DOP76 Real-world multicenter comparison of effectiveness between tofacitinib and vedolizumab in patients with Ulcerative Colitis after failure to at least one anti-TNF agent</title>
            <author role="aut">
              <persName>
                <forename type="first">A.</forename>
                <surname>Buisson</surname>
              </persName>
              <idno type="halauthorid">409898-0</idno>
              <affiliation ref="#struct-380171"/>
            </author>
            <author role="aut">
              <persName>
                <forename type="first">M.</forename>
                <surname>Nachury</surname>
              </persName>
              <idno type="halauthorid">1143367-0</idno>
              <affiliation ref="#struct-300097"/>
            </author>
            <author role="aut">
              <persName>
                <forename type="first">Mathurin</forename>
                <surname>Fumery</surname>
              </persName>
              <email type="md5">48f411b12926dedbdb87bcda8f30fcd0</email>
              <email type="domain">chu-amiens.fr</email>
              <idno type="idhal" notation="numeric">774088</idno>
              <idno type="halauthorid" notation="string">913740-774088</idno>
              <idno type="ORCID">https://orcid.org/0000-0002-2337-2902</idno>
              <idno type="IDREF">https://www.idref.fr/170096289</idno>
              <idno type="RESEARCHERID">http://www.researcherid.com/rid/DWQ-0326-2022</idno>
              <idno type="RESEARCHERID">http://www.researcherid.com/rid/http://www.researcherid.com/rid/DWQ-0326-2022</idno>
              <affiliation ref="#struct-300535"/>
              <affiliation ref="#struct-543674"/>
            </author>
            <author role="aut">
              <persName>
                <forename type="first">T.</forename>
                <surname>Guilmoteau</surname>
              </persName>
              <idno type="halauthorid">2501810-0</idno>
              <affiliation ref="#struct-380171"/>
            </author>
            <author role="aut">
              <persName>
                <forename type="first">E.</forename>
                <surname>Leclerc</surname>
              </persName>
              <idno type="halauthorid">131155-0</idno>
              <affiliation ref="#struct-26646"/>
            </author>
            <author role="aut">
              <persName>
                <forename type="first">R.</forename>
                <surname>Altwegg</surname>
              </persName>
              <idno type="halauthorid">1039684-0</idno>
              <affiliation ref="#struct-258773"/>
            </author>
            <author role="aut">
              <persName>
                <forename type="first">M.</forename>
                <surname>Serrero</surname>
              </persName>
              <idno type="halauthorid">1264314-0</idno>
              <affiliation ref="#struct-300073"/>
            </author>
            <author role="aut">
              <persName>
                <forename type="first">X.</forename>
                <surname>Treton</surname>
              </persName>
              <idno type="halauthorid">607498-0</idno>
              <affiliation ref="#struct-300068"/>
            </author>
            <author role="aut">
              <persName>
                <forename type="first">L.</forename>
                <surname>Vuitton</surname>
              </persName>
              <idno type="halauthorid">1264317-0</idno>
              <affiliation ref="#struct-300165"/>
            </author>
            <author role="aut">
              <persName>
                <forename type="first">B.</forename>
                <surname>Pereira</surname>
              </persName>
              <email type="md5">4cc794feab9259f201260b85e6b604cb</email>
              <email type="domain">chu-clermontferrand.fr</email>
              <idno type="idhal" notation="string">bruno-pereira</idno>
              <idno type="idhal" notation="numeric">949620</idno>
              <idno type="halauthorid" notation="string">421585-949620</idno>
              <idno type="ORCID">https://orcid.org/0000-0003-3778-7161</idno>
              <idno type="IDREF">https://www.idref.fr/181458675</idno>
              <idno type="VIAF">https://viaf.org/viaf/313568580</idno>
              <affiliation ref="#struct-300144"/>
            </author>
            <author role="aut">
              <persName>
                <forename type="first">A.</forename>
                <surname>Amiot</surname>
              </persName>
              <idno type="halauthorid">1264313-0</idno>
              <affiliation ref="#struct-366262"/>
            </author>
            <author role="aut">
              <persName>
                <forename type="first">G.</forename>
                <surname>Bouguen</surname>
              </persName>
              <idno type="halauthorid">588904-0</idno>
              <affiliation ref="#struct-2610"/>
              <affiliation ref="#struct-301327"/>
            </author>
            <editor role="depositor">
              <persName>
                <forename>Louise</forename>
                <surname>DESSAIVRE</surname>
              </persName>
              <email type="md5">685d55eef963fb90de2023edc9d11c27</email>
              <email type="domain">u-picardie.fr</email>
            </editor>
          </titleStmt>
          <editionStmt>
            <edition n="v1" type="current">
              <date type="whenSubmitted">2022-05-12 10:28:37</date>
              <date type="whenModified">2026-04-02 17:12:03</date>
              <date type="whenReleased">2022-05-12 10:28:37</date>
              <date type="whenProduced">2022-01-21</date>
              <ref type="externalLink" target="https://academic.oup.com/ecco-jcc/article-pdf/16/Supplement_1/i120/42250263/jjab232.115.pdf"/>
            </edition>
            <respStmt>
              <resp>contributor</resp>
              <name key="799781">
                <persName>
                  <forename>Louise</forename>
                  <surname>DESSAIVRE</surname>
                </persName>
                <email type="md5">685d55eef963fb90de2023edc9d11c27</email>
                <email type="domain">u-picardie.fr</email>
              </name>
            </respStmt>
          </editionStmt>
          <publicationStmt>
            <distributor>CCSD</distributor>
            <idno type="halId">hal-03665871</idno>
            <idno type="halUri">https://u-picardie.hal.science/hal-03665871</idno>
            <idno type="halBibtex">buisson:hal-03665871</idno>
            <idno type="halRefHtml">&lt;i&gt;Journal of Crohn's and Colitis&lt;/i&gt;, 2022, 16 (1), pp.I120. &lt;a target="_blank" href="https://dx.doi.org/10.1093/ecco-jcc/jjab232.115"&gt;&amp;#x27E8;10.1093/ecco-jcc/jjab232.115&amp;#x27E9;&lt;/a&gt;</idno>
            <idno type="halRef">Journal of Crohn's and Colitis, 2022, 16 (1), pp.I120. &amp;#x27E8;10.1093/ecco-jcc/jjab232.115&amp;#x27E9;</idno>
            <availability status="restricted"/>
          </publicationStmt>
          <seriesStmt>
            <idno type="stamp" n="UNIV-RENNES1">Université de Rennes 1</idno>
            <idno type="stamp" n="CNRS">CNRS - Centre national de la recherche scientifique</idno>
            <idno type="stamp" n="UNIV-PICARDIE">Université de Picardie Jules Verne</idno>
            <idno type="stamp" n="UNIV-LYON1">Université Claude Bernard - Lyon I</idno>
            <idno type="stamp" n="IRCELYON" corresp="UNIV-LYON1">Institut de recherches sur la catalyse et l'environnement de Lyon</idno>
            <idno type="stamp" n="APHP" corresp="INSERM">AP-HP</idno>
            <idno type="stamp" n="HL">Publications CHU Rennes</idno>
            <idno type="stamp" n="CIC">CIC-Rennes</idno>
            <idno type="stamp" n="CIC203">CIC-1414</idno>
            <idno type="stamp" n="NUMECAN">Nutrition, Métabolismes et Cancer</idno>
            <idno type="stamp" n="INC-CNRS">Institut de Chimie du CNRS</idno>
            <idno type="stamp" n="NUMECAN-EXPRES" corresp="NUMECAN">NUMECAN équipe EXPRES - Stress exogènes et endogènes, plasticité des réponses et pathologies</idno>
            <idno type="stamp" n="UR1-UFR-SVE">UFR SVE Sciences de la vie et de l'environnement</idno>
            <idno type="stamp" n="UR1-HAL">Publications labos UR1 dans HAL-Rennes 1</idno>
            <idno type="stamp" n="UR1-SDV">UR1 - publications SDV</idno>
            <idno type="stamp" n="TEST-UR-CSS">TEST Université de Rennes CSS</idno>
            <idno type="stamp" n="UNIV-RENNES">Université de Rennes</idno>
            <idno type="stamp" n="CHU-CLERMONTFERRAND">CHU DE CLERMONT FERRAND</idno>
            <idno type="stamp" n="UDL">UDL</idno>
            <idno type="stamp" n="UNIV-LYON">Université de Lyon</idno>
            <idno type="stamp" n="UR1-BIO-SA">Pôle UnivRennes - Biologie-Santé</idno>
            <idno type="stamp" n="U-PICARDIE">Université de Picardie Jules Verne</idno>
            <idno type="stamp" n="PERITOX" corresp="U-PICARDIE">Périnatalité et Risques Toxiques - UMR INERIS_I 1</idno>
          </seriesStmt>
          <notesStmt>
            <note type="audience" n="2">International</note>
            <note type="popular" n="0">No</note>
            <note type="peer" n="1">Yes</note>
          </notesStmt>
          <sourceDesc>
            <biblStruct>
              <analytic>
                <title xml:lang="en">DOP76 Real-world multicenter comparison of effectiveness between tofacitinib and vedolizumab in patients with Ulcerative Colitis after failure to at least one anti-TNF agent</title>
                <author role="aut">
                  <persName>
                    <forename type="first">A.</forename>
                    <surname>Buisson</surname>
                  </persName>
                  <idno type="halauthorid">409898-0</idno>
                  <affiliation ref="#struct-380171"/>
                </author>
                <author role="aut">
                  <persName>
                    <forename type="first">M.</forename>
                    <surname>Nachury</surname>
                  </persName>
                  <idno type="halauthorid">1143367-0</idno>
                  <affiliation ref="#struct-300097"/>
                </author>
                <author role="aut">
                  <persName>
                    <forename type="first">Mathurin</forename>
                    <surname>Fumery</surname>
                  </persName>
                  <email type="md5">48f411b12926dedbdb87bcda8f30fcd0</email>
                  <email type="domain">chu-amiens.fr</email>
                  <idno type="idhal" notation="numeric">774088</idno>
                  <idno type="halauthorid" notation="string">913740-774088</idno>
                  <idno type="ORCID">https://orcid.org/0000-0002-2337-2902</idno>
                  <idno type="IDREF">https://www.idref.fr/170096289</idno>
                  <idno type="RESEARCHERID">http://www.researcherid.com/rid/DWQ-0326-2022</idno>
                  <idno type="RESEARCHERID">http://www.researcherid.com/rid/http://www.researcherid.com/rid/DWQ-0326-2022</idno>
                  <affiliation ref="#struct-300535"/>
                  <affiliation ref="#struct-543674"/>
                </author>
                <author role="aut">
                  <persName>
                    <forename type="first">T.</forename>
                    <surname>Guilmoteau</surname>
                  </persName>
                  <idno type="halauthorid">2501810-0</idno>
                  <affiliation ref="#struct-380171"/>
                </author>
                <author role="aut">
                  <persName>
                    <forename type="first">E.</forename>
                    <surname>Leclerc</surname>
                  </persName>
                  <idno type="halauthorid">131155-0</idno>
                  <affiliation ref="#struct-26646"/>
                </author>
                <author role="aut">
                  <persName>
                    <forename type="first">R.</forename>
                    <surname>Altwegg</surname>
                  </persName>
                  <idno type="halauthorid">1039684-0</idno>
                  <affiliation ref="#struct-258773"/>
                </author>
                <author role="aut">
                  <persName>
                    <forename type="first">M.</forename>
                    <surname>Serrero</surname>
                  </persName>
                  <idno type="halauthorid">1264314-0</idno>
                  <affiliation ref="#struct-300073"/>
                </author>
                <author role="aut">
                  <persName>
                    <forename type="first">X.</forename>
                    <surname>Treton</surname>
                  </persName>
                  <idno type="halauthorid">607498-0</idno>
                  <affiliation ref="#struct-300068"/>
                </author>
                <author role="aut">
                  <persName>
                    <forename type="first">L.</forename>
                    <surname>Vuitton</surname>
                  </persName>
                  <idno type="halauthorid">1264317-0</idno>
                  <affiliation ref="#struct-300165"/>
                </author>
                <author role="aut">
                  <persName>
                    <forename type="first">B.</forename>
                    <surname>Pereira</surname>
                  </persName>
                  <email type="md5">4cc794feab9259f201260b85e6b604cb</email>
                  <email type="domain">chu-clermontferrand.fr</email>
                  <idno type="idhal" notation="string">bruno-pereira</idno>
                  <idno type="idhal" notation="numeric">949620</idno>
                  <idno type="halauthorid" notation="string">421585-949620</idno>
                  <idno type="ORCID">https://orcid.org/0000-0003-3778-7161</idno>
                  <idno type="IDREF">https://www.idref.fr/181458675</idno>
                  <idno type="VIAF">https://viaf.org/viaf/313568580</idno>
                  <affiliation ref="#struct-300144"/>
                </author>
                <author role="aut">
                  <persName>
                    <forename type="first">A.</forename>
                    <surname>Amiot</surname>
                  </persName>
                  <idno type="halauthorid">1264313-0</idno>
                  <affiliation ref="#struct-366262"/>
                </author>
                <author role="aut">
                  <persName>
                    <forename type="first">G.</forename>
                    <surname>Bouguen</surname>
                  </persName>
                  <idno type="halauthorid">588904-0</idno>
                  <affiliation ref="#struct-2610"/>
                  <affiliation ref="#struct-301327"/>
                </author>
              </analytic>
              <monogr>
                <idno type="halJournalId" status="VALID">120336</idno>
                <idno type="issn">1873-9946</idno>
                <idno type="eissn">1876-4479</idno>
                <title level="j">Journal of Crohn's and Colitis</title>
                <imprint>
                  <publisher>Elsevier - Oxford University Press</publisher>
                  <biblScope unit="volume">16</biblScope>
                  <biblScope unit="issue">1</biblScope>
                  <biblScope unit="pp">I120</biblScope>
                  <date type="datePub">2022-01-21</date>
                  <date type="dateEpub">2022-01-22</date>
                </imprint>
              </monogr>
              <idno type="doi">10.1093/ecco-jcc/jjab232.115</idno>
            </biblStruct>
          </sourceDesc>
          <profileDesc>
            <langUsage>
              <language ident="en">English</language>
            </langUsage>
            <textClass>
              <classCode scheme="halDomain" n="sdv">Life Sciences [q-bio]</classCode>
              <classCode scheme="halTypology" n="ART">Journal articles</classCode>
              <classCode scheme="halOldTypology" n="ART">Journal articles</classCode>
              <classCode scheme="halTreeTypology" n="ART">Journal articles</classCode>
            </textClass>
            <abstract xml:lang="en">
              <p>BackgroundSeveral therapeutic options are now available in ulcerative colitis after anti-TNF failure, but no data compared hitherto tofacitinib and vedolizumab.We compared the effectiveness of tofacitinib and vedolizumab in UC patients with prior exposure ≥ 1 anti-TNF.MethodsIn this multicentre retrospective study, we consecutively included all adult UC patients with partial Mayo score &gt; 2, with ≥ 1 prior anti-TNF agent and started either tofacitinib (10mg b.i.d ± decreased to 5 mg b.i.d from week 8 (W8)) or vedolizumab (300 mg IV at W0-W2-W6 -W14 [± additional W10]) between January 2019 and June 2021.The primary endpoint was corticosteroid-free clinical remission or CFREM (partial Mayo score ≤ 2) at W16. Secondary endpoints were endoscopic improvement (CFREM + endoscopic Mayo score ≤ 1) and mucosal healing (CFREM + endoscopic and histological remission defined as Nancy index ≤ 1).All the comparisons were performed using propensity score analyses (inverse probability of treatment weighting) adjusted on gender, smoking, UC duration and extent, number of prior biologics or prior primary failure to biologics, concomitant 5-ASA, steroids or immunosuppressive agents, and disease severity.ResultsOverall, 400 patients will be included. Among the 200 first patients, 87 and 112 received tofacitinib and vedolizumab, respectively (one missing patient). Except for more pancolitis (54.0% vs 38.4%, p=0.028), less immunosuppressive therapies (4.6% vs 27.7%, p &lt; 0.001), and higher rate of prior exposure ≥ 2 biologics (87.4% vs 37.5%, p &lt; 0.001) in tofacitinib arm, baseline characteristics were similar across the two groups including concomitant 5-ASA (10.3% vs 18.8%) and steroids (23.0% vs 31.2%). Vedolizumab infusion at W10 was performed in 34.3% while 42.5% received tofacitinib 10 mg b.i.d until W16.CFREM was achieved in 54.2% and 42.5% in tofacitinib and vedolizumab, respectively p=0.089). The rate of CFREM at W16 was 57.4% vs 51.1% (p=0.77) after one biologic, 55.4% vs 41.8% (p=0.61) after 2 biologics, 56.9% vs 6.3% (p=0.007) after at least 3 biologics, and 59.0% vs 33.3% (p=0.17) in the subgroup with partial Mayo score ≥ 6, in tofacitinib and vedolizumab groups, respectively.Tofacitinib was more effective than vedolizumab to achieve CFREM at W16 in patients with primary failure to at least biologic (71.6% vs 30.8%, p=0.049).Among 177 patients, endoscopic improvement was higher in patients treated with tofacitinib (33.6 % vs 7.1%, p=0.048). Mucosal healing was observed in 6.4% vs 3.8% in tofacitinib and vedolizumab arms, respectively (p=0.27).ConclusionTofacitinib and vedolizumab are effective after failure to anti-TNF agents. Tofacitinib seems to be more effective in case of primary failure to biologics and multiple therapeutic failure.</p>
            </abstract>
          </profileDesc>
        </biblFull>
      </listBibl>
    </body>
    <back>
      <listOrg type="structures">
        <org type="institution" xml:id="struct-380171" status="VALID">
          <orgName>CHU Estaing [Clermont-Ferrand]</orgName>
          <desc>
            <address>
              <addrLine>1 Rue Lucie et Raymond Aubrac, 63100 Clermont-Ferrand</addrLine>
              <country key="FR"/>
            </address>
            <ref type="url">https://www.chu-clermontferrand.fr/les-sites/site-estaing</ref>
          </desc>
          <listRelation>
            <relation active="#struct-300144" type="direct"/>
          </listRelation>
        </org>
        <org type="regrouplaboratory" xml:id="struct-300097" status="VALID">
          <idno type="ROR">https://ror.org/05cpv3t46</idno>
          <orgName>Hôpital Claude Huriez [Lille]</orgName>
          <desc>
            <address>
              <addrLine>rue Michel Polonowski, 59000 Lille</addrLine>
              <country key="FR"/>
            </address>
            <ref type="url">https://www.chu-lille.fr/hopital-huriez/</ref>
          </desc>
          <listRelation>
            <relation active="#struct-425779" type="direct"/>
          </listRelation>
        </org>
        <org type="institution" xml:id="struct-300535" status="VALID">
          <orgName>CHU Amiens-Picardie</orgName>
          <desc>
            <address>
              <country key="FR"/>
            </address>
          </desc>
        </org>
        <org type="laboratory" xml:id="struct-543674" status="VALID">
          <idno type="IdRef">231516681</idno>
          <idno type="RNSR">200815522S</idno>
          <orgName>Périnatalité et Risques Toxiques - UMR INERIS_I 1 UPJV</orgName>
          <orgName type="acronym">PERITOX</orgName>
          <date type="start">2008-01-01</date>
          <desc>
            <address>
              <addrLine>Université de Picardie Jules Verne - CURS - CHU Sud avenue Laënnec - 80054 AMIENS CEDEX 1</addrLine>
              <country key="FR"/>
            </address>
            <ref type="url">https://peritox.u-picardie.fr</ref>
          </desc>
          <listRelation>
            <relation name="UMR_I 1" active="#struct-3186" type="direct"/>
            <relation name="UMR_I 1" active="#struct-300258" type="direct"/>
            <relation name="UMR_I 1" active="#struct-300535" type="direct"/>
          </listRelation>
        </org>
        <org type="laboratory" xml:id="struct-26646" status="VALID">
          <idno type="IdRef">027934608</idno>
          <idno type="ISNI">0000 0004 0370 7677</idno>
          <idno type="RNSR">200711921G</idno>
          <idno type="ROR">https://ror.org/04fy20a51</idno>
          <orgName>Institut de recherches sur la catalyse et l'environnement de Lyon</orgName>
          <orgName type="acronym">IRCELYON</orgName>
          <date type="start">2007-01-01</date>
          <desc>
            <address>
              <addrLine>2 avenue Albert Einstein 69226 Villeurbanne cedex</addrLine>
              <country key="FR"/>
            </address>
          </desc>
          <listRelation>
            <relation active="#struct-194495" type="direct"/>
            <relation active="#struct-301088" type="indirect"/>
            <relation active="#struct-341038" type="direct"/>
            <relation name="UMR5256" active="#struct-441569" type="direct"/>
          </listRelation>
        </org>
        <org type="regroupinstitution" xml:id="struct-258773" status="VALID">
          <idno type="ISNI">000000009961060X</idno>
          <idno type="ROR">https://ror.org/04m6sq715</idno>
          <orgName>Centre Hospitalier Régional Universitaire [Montpellier]</orgName>
          <orgName type="acronym">CHRU Montpellier</orgName>
          <desc>
            <address>
              <addrLine>191 avenue du doyen Gaston Giraud 34295 Montpellier</addrLine>
              <country key="FR"/>
            </address>
            <ref type="url">https://www.chu-montpellier.fr/fr/</ref>
          </desc>
        </org>
        <org type="regroupinstitution" xml:id="struct-300073" status="VALID">
          <idno type="ROR">https://ror.org/002cp4060</idno>
          <orgName>Assistance Publique - Hôpitaux de Marseille</orgName>
          <orgName type="acronym">APHM</orgName>
          <desc>
            <address>
              <addrLine>Direction générale AP-HM80, rue Brochier13 354 Marseille Cedex 5</addrLine>
              <country key="FR"/>
            </address>
            <ref type="url">http://fr.ap-hm.fr/</ref>
          </desc>
        </org>
        <org type="regroupinstitution" xml:id="struct-300068" status="VALID">
          <idno type="ROR">https://ror.org/00pg5jh14</idno>
          <orgName>Assistance publique - Hôpitaux de Paris (AP-HP)</orgName>
          <orgName type="acronym">AP-HP</orgName>
          <desc>
            <address>
              <country key="FR"/>
            </address>
          </desc>
        </org>
        <org type="institution" xml:id="struct-300165" status="VALID">
          <orgName>Centre Hospitalier Régional Universitaire de Besançon</orgName>
          <orgName type="acronym">CHRU Besançon</orgName>
          <desc>
            <address>
              <addrLine>3, boulevard A. Fleming - 25030 Besançon Cedex</addrLine>
              <country key="FR"/>
            </address>
            <ref type="url">http://www.chu-besancon.fr/</ref>
          </desc>
        </org>
        <org type="regroupinstitution" xml:id="struct-300144" status="VALID">
          <idno type="IdRef">026606836</idno>
          <idno type="ISNI">0000000406394151</idno>
          <idno type="ROR">https://ror.org/02tcf7a68</idno>
          <orgName>CHU Clermont-Ferrand</orgName>
          <desc>
            <address>
              <country key="FR"/>
            </address>
            <ref type="url">https://www.chu-clermontferrand.fr/</ref>
          </desc>
        </org>
        <org type="institution" xml:id="struct-366262" status="VALID">
          <idno type="ROR">https://ror.org/04m61mj84</idno>
          <orgName>CHU Henri Mondor [Créteil]</orgName>
          <desc>
            <address>
              <addrLine>51, avenue du Maréchal de Lattre de Tassigny 94000 Créteil</addrLine>
              <country key="FR"/>
            </address>
          </desc>
          <listRelation>
            <relation active="#struct-103061" type="direct"/>
            <relation active="#struct-300068" type="direct"/>
          </listRelation>
        </org>
        <org type="laboratory" xml:id="struct-2610" status="VALID">
          <idno type="RNSR">200220115K</idno>
          <idno type="ROR">https://ror.org/02baj6743</idno>
          <orgName>Centre d'Investigation Clinique [Rennes]</orgName>
          <orgName type="acronym">CIC</orgName>
          <date type="start">2002-01-01</date>
          <desc>
            <address>
              <addrLine>Rue Henri Le Guilloux - Pavillon Clémenceau 35033 Rennes Cedex 9</addrLine>
              <country key="FR"/>
            </address>
            <ref type="url">http://www.cic-rennes.fr/</ref>
          </desc>
          <listRelation>
            <relation active="#struct-105160" type="direct"/>
            <relation active="#struct-301327" type="direct"/>
            <relation name="CIC1414" active="#struct-303623" type="direct"/>
          </listRelation>
        </org>
        <org type="institution" xml:id="struct-301327" status="VALID">
          <idno type="ROR">https://ror.org/05qec5a53</idno>
          <orgName>Centre Hospitalier Universitaire de Rennes [CHU Rennes] = Rennes University Hospital [Pontchaillou]</orgName>
          <desc>
            <address>
              <addrLine>2 Rue Henri le Guilloux, 35000 Rennes</addrLine>
              <country key="FR"/>
            </address>
            <ref type="url">https://www.chu-rennes.fr/</ref>
          </desc>
        </org>
        <org type="institution" xml:id="struct-425779" status="VALID">
          <idno type="IdRef">034424636</idno>
          <idno type="ISNI">0000000404718845</idno>
          <idno type="ROR">https://ror.org/02ppyfa04</idno>
          <idno type="Wikidata">Q2945741</idno>
          <orgName>Centre Hospitalier Régional Universitaire [CHU Lille]</orgName>
          <orgName type="acronym">CHRU Lille</orgName>
          <desc>
            <address>
              <addrLine>CHU/CHRU Lille - 2, avenue Oscar Lambret - 59037 Lille Cedex</addrLine>
              <country key="FR"/>
            </address>
            <ref type="url">http://www.chru-lille.fr/</ref>
          </desc>
        </org>
        <org type="institution" xml:id="struct-3186" status="VALID">
          <idno type="ROR">https://ror.org/034yrjf77</idno>
          <orgName>Institut National de l'Environnement Industriel et des Risques</orgName>
          <orgName type="acronym">INERIS</orgName>
          <desc>
            <address>
              <addrLine>Verneuil-en-Halatte ; Nancy ; Aix en Provence</addrLine>
              <country key="FR"/>
            </address>
            <ref type="url">http://www.ineris.fr/</ref>
          </desc>
        </org>
        <org type="institution" xml:id="struct-300258" status="VALID">
          <idno type="IdRef">026403714</idno>
          <idno type="ISNI">0000 0001 0789 1385</idno>
          <idno type="ROR">https://ror.org/01gyxrk03</idno>
          <orgName>Université de Picardie Jules Verne</orgName>
          <orgName type="acronym">UPJV</orgName>
          <desc>
            <address>
              <addrLine>Chemin du Thil - 80000 Amiens</addrLine>
              <country key="FR"/>
            </address>
            <ref type="url">https://www.u-picardie.fr/</ref>
          </desc>
        </org>
        <org type="institution" xml:id="struct-194495" status="VALID">
          <idno type="IdRef">026402823</idno>
          <idno type="ISNI">0000000121686185</idno>
          <idno type="ROR">https://ror.org/029brtt94</idno>
          <orgName>Université Claude Bernard Lyon 1</orgName>
          <orgName type="acronym">UCBL</orgName>
          <desc>
            <address>
              <addrLine>43, boulevard du 11 novembre 1918, 69622 Villeurbanne cedex</addrLine>
              <country key="FR"/>
            </address>
            <ref type="url">http://www.univ-lyon1.fr/</ref>
          </desc>
          <listRelation>
            <relation active="#struct-301088" type="direct"/>
          </listRelation>
        </org>
        <org type="regroupinstitution" xml:id="struct-301088" status="VALID">
          <idno type="ROR">https://ror.org/01rk35k63</idno>
          <orgName>Université de Lyon</orgName>
          <desc>
            <address>
              <addrLine>92 rue Pasteur - CS 30122, 69361 Lyon Cedex 07</addrLine>
              <country key="FR"/>
            </address>
            <ref type="url">https://www.universite-lyon.fr/</ref>
          </desc>
        </org>
        <org type="institution" xml:id="struct-341038" status="VALID">
          <idno type="IdRef">232435103</idno>
          <idno type="ISNI">000000010626358X</idno>
          <idno type="ROR">https://ror.org/02cte4b68</idno>
          <orgName>Institut de Chimie - CNRS Chimie</orgName>
          <orgName type="acronym">INC-CNRS</orgName>
          <date type="start">2009-10-01</date>
          <desc>
            <address>
              <addrLine>CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE3 rue Michel-Ange75794 PARIS CEDEX 16 - France</addrLine>
              <country key="FR"/>
            </address>
            <ref type="url">http://www.cnrs.fr/inc</ref>
          </desc>
        </org>
        <org type="regroupinstitution" xml:id="struct-441569" status="VALID">
          <idno type="IdRef">02636817X</idno>
          <idno type="ISNI">0000000122597504</idno>
          <idno type="ROR">https://ror.org/02feahw73</idno>
          <orgName>Centre National de la Recherche Scientifique</orgName>
          <orgName type="acronym">CNRS</orgName>
          <date type="start">1939-10-19</date>
          <desc>
            <address>
              <country key="FR"/>
            </address>
            <ref type="url">https://www.cnrs.fr/</ref>
          </desc>
        </org>
        <org type="regroupinstitution" xml:id="struct-103061" status="VALID">
          <orgName>Groupe Henri Mondor-Albert Chenevier</orgName>
          <desc>
            <address>
              <addrLine>Créteil</addrLine>
              <country key="FR"/>
            </address>
          </desc>
        </org>
        <org type="institution" xml:id="struct-105160" status="VALID">
          <idno type="IdRef">26693823X</idno>
          <idno type="ROR">https://ror.org/015m7wh34</idno>
          <orgName>Université de Rennes</orgName>
          <orgName type="acronym">UR</orgName>
          <desc>
            <address>
              <addrLine>Campus de Beaulieu, 263 avenue Général Leclerc, CS 74205, 35042 RENNES CEDEX</addrLine>
              <country key="FR"/>
            </address>
            <ref type="url">https://www.univ-rennes.fr/</ref>
          </desc>
        </org>
        <org type="institution" xml:id="struct-303623" status="VALID">
          <idno type="IdRef">026388278</idno>
          <idno type="ROR">https://ror.org/02vjkv261</idno>
          <orgName>Institut National de la Santé et de la Recherche Médicale</orgName>
          <orgName type="acronym">INSERM</orgName>
          <desc>
            <address>
              <addrLine>101, rue de Tolbiac, 75013 Paris</addrLine>
              <country key="FR"/>
            </address>
            <ref type="url">http://www.inserm.fr</ref>
          </desc>
        </org>
      </listOrg>
    </back>
  </text>
</TEI>